Adverse events · adults with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adults with a confirmed diagnosis of mild COVID‐19, of whom only 10% (219/2132) participants had received ≥ 1 vaccination
Inhaled corticosteroids plus standard care showed no clear difference in adverse events compared with standard care (with or without placebo) (low certainty).
1 finding from 1 review
Adverse events · mild asthma
As‐required FABA/ICS inhalers showed no clear difference in adverse events compared with regular inhaled steroid (moderate certainty).
1 finding from 1 review
Adverse events · mild asthma
As‐required FABA/ICS inhalers probably leads to lower adverse events compared with as‐required FABA inhalers (moderate certainty).
1 finding from 1 review
Adverse events · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
24 participants
GRADE not reported
Adverse events · Adults with COPD
1 finding from 1 review
Adverse events · participants with chronic cough
1 finding from 1 review
Adverse events · autumn asthma exacerbations in children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · autumn asthma exacerbations in children
Omalizumab showed no clear difference in adverse events compared with usual care (moderate certainty).
1 finding from 1 review
Adverse events · autumn asthma exacerbations in children
A boost of inhaled corticosteroids showed no clear difference in adverse events compared with usual care (moderate certainty).
1 finding from 1 review
Adverse events · autumn asthma exacerbations in children
Leukotriene receptor antagonist showed no clear difference in adverse events compared with usual care (high certainty).
1 finding from 1 review
Adverse events · patients with acute asthma
Intramuscular corticosteroids showed no clear difference in adverse events compared with oral corticosteroids (low certainty).
1 finding from 1 review
Adverse events · children with asthma
1 finding from 1 review
Intervention not reported
Adverse events · adolescents with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · People with asthma (mostly mild or moderate)
1 finding from 1 review
Adverse events · people with asthma
1 finding from 1 review
no estimate extracted
8 participants
Moderate
Adverse events · Preschool children (<6 years)
Intermittent ICS showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · School‐aged children and adults
Intermittent ICS showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment
The intervention showed no clear difference in adverse events (low certainty).
1 finding from 1 review
Adverse events · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review